What is the consequence of an abnormal lipid profile in patients with type 2 diabetes or the metabolic syndrome?

Atherosclerosis Supplements

Volumn 6, Issue 3 SPEC. ISS., 2005, Pages 11-14

  Windler, Eberhard ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Coronary heart disease; HDL C; LDL C; Lipid profile; Type 2 diabetes

Indexed keywords

ATORVASTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; TRIACYLGLYCEROL;

AGE DISTRIBUTION; ATHEROGENESIS; CARDIOVASCULAR RISK; CHOLESTEROL TRANSPORT; CLINICAL TRIAL; CONFERENCE PAPER; CORONARY ARTERY DISEASE; EVIDENCE BASED MEDICINE; GROUPS BY AGE; HEART INFARCTION; HUMAN; HYPERGLYCEMIA; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID OXIDATION; LIPIDOSIS; LIPOPROTEIN BLOOD LEVEL; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 23744453870     PISSN: 15675688     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosissup.2005.06.003     Document Type: Conference Paper

References (10)

1. G. Assmann, P. Cullen, and H. Schulte Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular munster (PROCAM) study Circulation 105 2002 310 315
2. R.D. Siegel, A. Cupples, E.J. Schaefer, and P.W. Wilson Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study Metabolism 45 1996 1267 1272
3. P. Libby Reducing the risk of atherosclerosis: the role of high-density lipoprotein cholesterol Br J Cardiol 11 Suppl 2 2004 S3 S6
4. G. Assmann Symposium introduction Br J Cardiol 11 Suppl 2 2004 S1 S2
5. S.M. Haffner, M.P. Stern, H.P. Hazuda, B.D. Mitchell, and J.K. Patterson Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 263 1990 2893 2898
6. W. Rathmann, B. Haastert, and A. Icks High prevalence of undiagnosed diabetes mellitus in southern Germany: target populations for efficient screening. The KORA survey 2000 Diabetologia 46 2003 182 189
7. W.P. Castelli Cardiovascular disease and multifactorial risk: challenge of the 1980s Am Heart J 106 1983 1191 1200
8. T. Gordon, W.P. Castelli, M.C. Hjortland, W.B. Kannel, and T.R. Dawber High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study Am J Med 62 1977 707 714
9. H.M. Colhoun, D.J. Betteridge, and P.N. Durrington Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial Lancet 364 2004 685 696
10. Scandinavian Simvastatin Survival Study Group Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389